ECP
AONCW

Empyrean Capital Partners’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Empyrean Capital Partners’s Portfolio AONCW Stock Details AONCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-125,000
Closed -$50K – 177
2022
Q1 		$50K Hold
125,000
– – ﹤0.01% 189
2021
Q4 		$82K Hold
125,000
– – ﹤0.01% 179
2021
Q3 		$86K Buy
+125,000
New +$99.9K ﹤0.01% 183

Other funds holding AONCW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
RA
Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Empyrean Capital Partners's AONCW Position: Q2 2022 in Review

Empyrean Capital Partners sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2022, closing a stake of 125,000 shares — an estimated $50K sold.

Empyrean Capital Partners first reported a position in AONCW in Q3 2021 and held it in 3 quarters. The position peaked at $86K in Q3 2021. 45 funds tracked by Wall St. Rank hold AONCW as of Q2 2022.

  • Empyrean Capital Partners reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2022 after selling out during the quarter.
  • Empyrean Capital Partners sold 125,000 American Oncology Network, Inc. Warrant shares in Q2 2022, an estimated $50K.
  • Empyrean Capital Partners first reported a position in American Oncology Network, Inc. Warrant in Q3 2021 and held it in 3 quarters.
  • Empyrean Capital Partners's American Oncology Network, Inc. Warrant position peaked at $86K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2022.

Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.